Ruxolitinib( Purity > 99% by HPLC)

Product Name: Ruxolitinib
 CAT#: A-2208

Request Ruxolitinib
 Synonym: INCB-018424; INCB 018424; INCB018424; INC424; IN C424; INC-424; INCB18424; INCB 18424; INCB-18424; trade name:J akafi and Jakavi ,

Ruxolitinib Chemical Structure
Ruxolitinibchemical structure

5 stars, based on 1836 reviews

IUPAC/Chemical name:

Price of Ruxolitinib

We offer a substantial discount on larger orders,
please inquire via sales@activebiochem.com
or Fax: 1-201-884-1288 (USA Fax#)


Biological Activity
Ruxolitinib, also known as INC424 and INCB18424 or INCB018424, is an orally bioavailable Janus-associated kinase (JAK) inhibitor with potential antineoplastic and immunomodulating activities. Ruxolitinib specifically binds to and inhibits protein tyrosine kinases JAK 1 and 2, which may lead to a reduction in inflammation and an inhibition of cellular proliferation. The JAK-STAT (signal transducer and activator of transcription) pathway plays a key role in the signaling of many cytokines and growth factors and is involved in cellular proliferation, growth, hematopoiesis, and the immune response; JAK kinases may be upregulated in inflammatory diseases, myeloproliferative disorders, and various malignancies. In November 2011, Ruxolitinib was approved by the U.S. Food and Drug Administration for the treatment of intermediate or high-risk myelofibrosis based on results of the COMFORT-I and COMFORT-II Trials.
Technical Data

Purity: >99%
CAS#:941678-49-5
Chemical Formula:C17H18N6
Molecular Weight:306.37
Ruxolitinib MSDSRuxolitinib CoA

IUPAC/Chemical name:(R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile
Canonical SMILES:
Reference





Purchase(buy) Ruxolitinib at Active Biochem and the United State(U.S.), Germany, Japan, France,United Kingdom(UK),Switzerland, Australia distributors.